Graney & King’s iShares MSCI EAFE ETF EFA Stock Holding History

Graney & King’s Portfolio EFA Stock Details EFA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-99	Closed	-$9.24K	–	360
2025 Q3	$9.24K	Hold	99	–	–	0.01%	238
2025 Q2	$8.85K	Hold	99	–	–	0.01%	229
2025 Q1	$8.09K	Hold	99	–	–	0.01%	226
2024 Q4	$7.49K	Buy	+99	New	+$7.84K	0.01%	224

Other funds holding EFA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

NMIMC

Northwestern Mutual Investment Management Company Milwaukee, Wisconsin $6.6B AUM 19.75% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Graney & King's EFA Position: Q4 2025 in Review

Graney & King sold out of iShares MSCI EAFE ETF (EFA) in Q4 2025, closing a stake of 99 shares — an estimated $9.24K sold.

Graney & King first reported a position in EFA in Q4 2024 and held it in 4 quarters. The position peaked at $9.24K in Q3 2025. 2,208 funds tracked by Wall St. Rank hold EFA as of Q4 2025.

Graney & King reported no remaining iShares MSCI EAFE ETF position as of Q4 2025 after selling out during the quarter.
Graney & King sold 99 iShares MSCI EAFE ETF shares in Q4 2025, an estimated $9.24K.
Graney & King first reported a position in iShares MSCI EAFE ETF in Q4 2024 and held it in 4 quarters.
Graney & King's iShares MSCI EAFE ETF position peaked at $9.24K in Q3 2025.
2,208 funds tracked by Wall St. Rank held iShares MSCI EAFE ETF as of Q4 2025.

Based on Graney & King's 13F filing for Q4 2025, filed 13 Feb 2026.